Donanemab, a new drug for early Alzheimer’s, significantly slowed progression of the disease in clinical trial results. Learn more about the treatment.| Alzheimer’s Association
Mild cognitive impairment – learn about MCI symptoms, diagnosis, causes, treatments and how this disorder relates to Alzheimer's and other dementias.| Alzheimer’s Association
Read the 2024 report to understand the burden of Alzheimer's and dementia on individuals, caregivers, government and the nation's health care system.| Alzheimer’s Association